Steven Cohen Vericel Corp Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $11.4 Million - $13.7 Million	-369,924 Reduced 59.9%	247,674 $8.82 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $3.7 Million - $4.58 Million	116,712 Added 23.3%	617,598 $20.7 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $12.6 Million - $16.6 Million	-433,893 Reduced 46.42%	500,886 $18.8 Million
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $22.3 Million - $29.3 Million	934,779 New	934,779 $27.4 Million
Q3 2019 Nov 15, 2019	SELL	$14.93 - $19.83 $3.26 Million - $4.33 Million	-218,368 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $2.83 Million - $3.56 Million	-188,532 Reduced 46.33%	218,368 $4.13 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $6.6 Million - $8.26 Million	406,900 New	406,900 $7.13 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $3.6 Million - $6.16 Million	-333,938 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $3.04 Million - $4.94 Million	333,938 New	333,938 $4.73 Million

292

49.4M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.1B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.